Anthurium Solutions, Inc. v. MedQuist, Inc. et al, No. 2:07-cv-00484 (E.D. Tex. Feb. 9, 2009)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

I. Introduction Anthurium Solutions, Inc. (“Anthurium”) f iled its complaint against MedQuist, Inc. (“MedQuist”), Arrendale Associat es, Inc. (“AAI”), and Spheris, Inc. (“Spheris”) (collectively, “defendants”) on November 6, 2007, alleging patent infringement. Anthurium accuses the defendants of infringing U.S. Patent No. 7,031,998 (“the ‘998 patent), which was filed on May 29, 2003, as U.S. Patent Application No. 10/389,116. The ‘998 patent is a continuation of U.S. Application No. 09/694,884, filed on October 24, 2000, now U.S. Patent Application No.